U.S. markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
144.10-1.53 (-1.05%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/30/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
8.08B6.12B5.52B8.38B7.26B
Enterprise Value 3
8.63B6.91B6.20B9.08B8.13B
Trailing P/E
63.0422.9910.9714.3311.60
Forward P/E 1
9.229.787.608.597.26
PEG Ratio (5 yr expected) 1
4.98N/A4.011.340.83
Price/Sales (ttm)
3.712.882.664.233.83
Price/Book (mrq)
2.572.181.782.742.43
Enterprise Value/Revenue 3
3.8912.2811.6015.6115.12
Enterprise Value/EBITDA 6
14.9326.03-50.2638.3240.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 312.04%
S&P500 52-Week Change 36.23%
52 Week High 3156.26
52 Week Low 386.88
50-Day Moving Average 3145.15
200-Day Moving Average 3122.92

Share Statistics

Avg Vol (3 month) 3755.33k
Avg Vol (10 day) 3424.18k
Shares Outstanding 555.46M
Float 50.41M
% Held by Insiders 12.84%
% Held by Institutions 196.73%
Shares Short (Oct 14, 2020) 44.17M
Short Ratio (Oct 14, 2020) 44.3
Short % of Float (Oct 14, 2020) 47.71%
Short % of Shares Outstanding (Oct 14, 2020) 47.51%
Shares Short (prior month Sep 14, 2020) 43.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 6.01%
Operating Margin (ttm)29.36%

Management Effectiveness

Return on Assets (ttm)7.04%
Return on Equity (ttm)4.35%

Income Statement

Revenue (ttm)2.22B
Revenue Per Share (ttm)39.50
Quarterly Revenue Growth (yoy)5.30%
Gross Profit (ttm)2.03B
EBITDA 975.85M
Net Income Avi to Common (ttm)133.24M
Diluted EPS (ttm)2.36
Quarterly Earnings Growth (yoy)-56.20%

Balance Sheet

Total Cash (mrq)1.7B
Total Cash Per Share (mrq)30.58
Total Debt (mrq)2.27B
Total Debt/Equity (mrq)72.11
Current Ratio (mrq)5.62
Book Value Per Share (mrq)56.65

Cash Flow Statement

Operating Cash Flow (ttm)880.79M
Levered Free Cash Flow (ttm)356.46M